For visceral fat specifically, peptides targeting visceral fat loss include compounds that may require shorter treatment durations than GLP-1 agonists
Many people find that taking GLP-1s quiets stressful food noise that previously occupied their thoughts
These drugs don't prevent muscle loss that can happen when you eat too little, and they don't repair deeper issues like sluggish mitochondria, toxin buildup, gut imbalances, inflammation, or a reset metabolic thermostat. In other words, they're powerful tools but real, lasting health still depends on addressing the root causes
I dont even think about it anymore. 'Promising' for alcohol use disorder, but more data needed Christian Hendershot, an associate professor at the Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill, is leading a clinical trial that will investigate if Ozempic or Wegovy reduces the cravings to drink
Perlman, R